
Sunil Laxminarayana Mundra
About Sunil Laxminarayana Mundra
Data last updated:
Sunil Laxminarayana Mundra is a Managing Director at Natural Capsules Limited (since 2011), Managing Director at Natural Biogenex Private Limited (since 2020) and Director at Tajos Investments Private Limited (since 1994), and holds 2 more current directorships. The companies operate in Pharma, Financial Services and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹171 Cr; the largest is Natural Capsules Limited at ₹170 Cr (FY 2025). Earlier, Sunil Laxminarayana Mundra was a Director at Supreem Pharmaceuticals Mysore Private Limited (2016–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Jun 2011 | 1993 | ₹170 Cr (FY 2025) | Active | |
| Managing Director | 23 Aug 2020 | 2020 | ₹1.44 Cr (FY 2025) | Active | |
| Director | 22 Feb 1994 | 1994 | ₹7.7 Lakh (FY 2022) | Active | |
| Director | 29 Sep 2018 | 2018 | Active | ||
| Director | 06 Feb 2014 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Sep 2016 | 1996 | ₹82.17 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunil Laxminarayana Mundra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Laxminarayana Mundra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Laxminarayana Mundra
Sunil Laxminarayana Mundra currently holds 5 directorships: Natural Capsules Limited (Managing Director, since 01 Jun 2011, revenue ₹170 Cr (FY 2025)); Natural Biogenex Private Limited (Managing Director, since 23 Aug 2020, revenue ₹1.44 Cr (FY 2025)); Tajos Investments Private Limited (Director, since 22 Feb 1994, revenue ₹7.7 Lakh (FY 2022)); Natural Phyto Pharma Private Limited (Director, since 29 Sep 2018); Square Plus Life Sciences Private Limited (Director, since 06 Feb 2014).
Sunil Laxminarayana Mundra was first appointed on 22 Feb 1994 as Director at Tajos Investments Private Limited. The most recent appointment on record is 23 Aug 2020 at Natural Biogenex Private Limited.
The 3 current companies of Sunil Laxminarayana Mundra that report revenue have a combined latest revenue of ₹171 Cr: Natural Capsules Limited ₹170 Cr (FY 2025); Natural Biogenex Private Limited ₹1.44 Cr (FY 2025); Tajos Investments Private Limited ₹7.7 Lakh (FY 2022).
Sunil Laxminarayana Mundra held 1 earlier board appointment: Supreem Pharmaceuticals Mysore Private Limited (Director, 22 Sep 2016 to 31 Aug 2020).
The current boards of Sunil Laxminarayana Mundra's companies include Akshay Dutta (Natural Capsules Limited), Jyoti Mundra (Natural Capsules Limited), Laxminarayan Moondra (Natural Capsules Limited), Pramod Kasat (Natural Capsules Limited), Raj Kishore Prasad (Natural Capsules Limited), Sathyanarayana Mundra (Natural Capsules Limited), among others.